G. Taghipour
About
G. Taghipour is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology.
According to data from OpenAlex, G. Taghipour has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 14 papers in Genetics and 10 papers in Oncology. Recurrent topics in G. Taghipour's work include Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Viral-associated cancers and disorders (7 papers). G. Taghipour is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Viral-associated cancers and disorders (7 papers). G. Taghipour collaborates with scholars based in United Kingdom, France and Spain. G. Taghipour's co-authors include Anthony H. Goldstone, Rachel Pearce, A. H. Goldstone, Norbert Schmitz, AH Goldstone, John Sweetenham, AK McMillan, Rajesh Chopra, DC Linch and Didier Blaise and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.
In The Last Decade
G. Taghipour
22 papers receiving 1.3k citations
Peers
G. Taghipour
M. Sextro Germany
Monica Balzarotti Italy
C Gisselbrecht France
PJ Bierman United States
T. Lister United Kingdom
P. Solal-Céligny France
J. Matthews United Kingdom
DD Weisenburger United States
Maike Nickelsen Germany
D. J. Moir United Kingdom
Citations per year, relative to G. Taghipour G. Taghipour (= 1×)
peers
M. Sextro
Countries citing papers authored by G. Taghipour
Since
Specialization
Citations
This map shows the geographic impact of G. Taghipour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Taghipour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Taghipour more than expected).
Fields of papers citing papers by G. Taghipour
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by G. Taghipour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Taghipour. The network helps show where G. Taghipour may publish in the future.
Co-authorship network of co-authors of G. Taghipour
This figure shows the co-authorship network connecting the top 25 collaborators of G. Taghipour. A scholar is included among the top collaborators of G. Taghipour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Taghipour. G. Taghipour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Montoto, Silvia, Carmen Canals, A. Z. S. Rohatiner, et al.. (2007). Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study. Leukemia. 21(11). 2324–2331.
2.
Kyriakou, Charalampia, Anna Sureda, G. Taghipour, et al.. (2007). Allogeneic Stem Cell Transplantation (Allo-SCT) in the Management of Advanced Waldenstrom’s Macroglobulinemia (WM).. Blood. 110(11). 619–619.
3.
Taghipour, G., Carmen Canals, Yves Béguin, et al.. (2006). Reduced-intensity conditioning and allogeneic stem cell transplantation in mantle cell lymphoma: an update from the Lymphoma Working Party of the EBMT. Bone Marrow Transplantation. 37.
4.
Montoto, Silvia, A. Z. S. Rohatiner, Carmen Canals, et al.. (2006). Long-term follow-up of high-dose treatment (HDT) with autologous haematopoietic progenitor cell support in 702 patients (pts.) with follicular lymphoma (FL). An EBMT registry study. Journal of Clinical Oncology. 24(18_suppl). 7526–7526.
5.
Peniket, Andy, M C Ruiz de Elvira, G. Taghipour, et al.. (2003). An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplantation. 31(8). 667–678.
6.
Williams, C. D., Claire Harrison, T. Lister, et al.. (2001). High-Dose Therapy and Autologous Stem-Cell Support for Chemosensitive Transformed Low-Grade Follicular Non-Hodgkin’s Lymphoma: A Case-Matched Study From the European Bone Marrow Transplant Registry. Journal of Clinical Oncology. 19(3). 727–735.
7.
Taghipour, G., et al.. (1999). Matched unrelated donor (MUD) bone marrow transplantation for adults and children with non-Hodgkin's lymphoma and Hodgkin's lymphoma: preliminary analysis of 56 cases reported to EBMT lymphoma registry.. Blood. 94(10).
8.
Sweetenham, John, Angelo Michele Carella, G. Taghipour, et al.. (1999). High-Dose Therapy and Autologous Stem-Cell Transplantation for Adult Patients With Hodgkin's Disease Who Do Not Enter Remission After Induction Chemotherapy: Results in 175 Patients Reported to the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology. 17(10). 3101–3109.
9.
Vandenberghe, Elisabeth, Rachel Pearce, G. Taghipour, L Fouillard, & A. H. Goldstone. (1997). Role of a second transplant in the management of poor-prognosis lymphomas: a report from the European Blood and Bone Marrow Registry.. Journal of Clinical Oncology. 15(4). 1595–1600.
10.
Taghipour, G., et al.. (1997). High-dose therapy and autologous stem cell rescue for patients with Hodgkin’s disease in first relapse after chemotherapy: results from the EBMT. Bone Marrow Transplantation. 20(9). 745–752.
11.
Majolino, Ignazio, R Pearce, G. Taghipour, & A. H. Goldstone. (1997). Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.. Journal of Clinical Oncology. 15(2). 509–517.
12.
Sweetenham, John, Rachel Pearce, G. Taghipour, et al.. (1996). Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation.. Journal of Clinical Oncology. 14(9). 2465–2472.
13.
Bradley, Susan J., et al.. (1995). First Remission Autologous Bone Marrow Transplantation for Hodgkin's Disease- Preliminary EBMT Data. Leukemia & lymphoma. 15(sup1). 51–53.
14.
Sweetenham, John, et al.. (1994). High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation.. Journal of Clinical Oncology. 12(7). 1358–1365.
15.
Pearce, Rachel, et al.. (1994). Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: A case-controlled analysis of the EBMT Registry data. Annals of Oncology. 5. S151–S153.
16.
Williams, C. D., et al.. (1994). Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry.. Journal of Clinical Oncology. 12(11). 2415–2422.
17.
Sweetenham, John, SJ Proctor, Didier Blaise, et al.. (1994). High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma: The EBMT experience. Annals of Oncology. 5. S155–S159.
18.
Chopra, Rajesh, et al.. (1993). The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight- year study of 155 patients. Blood. 81(5). 1137–1145.
19.
Chopra, Rajesh, AK McMillan, DC Linch, et al.. (1993). The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight- year study of 155 patients. Blood. 81(5). 1137–1145.
20.
Gribben, John G., Anthony H. Goldstone, David C. Linch, et al.. (1989). Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy.. Journal of Clinical Oncology. 7(11). 1621–1629.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by M. Sextro Breakdown of academic impact, for papers by Monica Balzarotti Breakdown of academic impact, for papers by C Gisselbrecht Breakdown of academic impact, for papers by PJ Bierman Breakdown of academic impact, for papers by T. Lister Breakdown of academic impact, for papers by P. Solal-Céligny Breakdown of academic impact, for papers by J. Matthews Breakdown of academic impact, for papers by DD Weisenburger Breakdown of academic impact, for papers by Maike Nickelsen Breakdown of academic impact, for papers by D. J. Moir